LESINURAD DISCONTINUED | LESINURAD | ATC M04AB05
MUSCULO-SKELETAL URAT1 INHIBITOR (KI = 7.3 MICROMOLAR) TREATMENT OF HYPERURICEMIA ASSOCIATED WITH GOUT REDUCES SERUM URIC ACID LEVELS BY INHIBITING THE FUNCTION OF TRANSPORTER PROTEINS INVOLVED IN URIC ACID REABSORPTION IN THE KIDNEY | ORAL | Cmax 14.8 MICROMOLAR Tmax 2.5 HOUR F 100 PERCENT VD 20 LITER PPB 98 PERCENT Cl 6 LITER / HOUR HT 5 HOUR SOLUBILITY SOLUBLE IN WATER | URIC ACID TRANSPORTER 1 (URAT1) ORGANIC ANION TRANSPORTER 4 (OAT4) | Solute carrier family 22 member 12 UNIPROT Q96S37 SLC22A12 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |